Physician

Lawrence A Gervasi, MD

According to 2025 Medicare claims, Lawrence Gervasi, MD (NPI: 1265400592) practices urology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is SOUTHWEST UROLOGY, LLC (NPI: 1962428136; TIN: 34-1509612) and primary practice location at 44130-3639.

Gervasi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 853 traditional Medicare patients, billed 12,115 HCPCS/CPT codes, and received $345,495 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,649 prescription claims across 947 beneficiaries totaling $7,463,935 in drug costs, led by Erleada (Apalutamide). DME data shows 53 claims. Open Payments data shows 266 records totaling $526,376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $452,690 and ending at $345,495. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $756,699 to $7,463,935. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $958 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$431K$862K2015 Medicare payment: $452,690 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $765,310 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $861,643 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $584,611 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $687,957 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $408,005 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $379,678 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $715,971 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $515,614 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $345,495 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201592416,869$452,690
201695219,522$765,310
201798218,620$861,643
201899416,304$584,611
201994516,138$687,957
202088819,376$408,005
202186618,213$379,678
202281314,893$715,971
202385813,073$515,614
202485312,115$345,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.7M$7.5M2015 Drug cost: $756,699 (USD; Tot_Drug_Cst)2016 Drug cost: $1,041,689 (USD; Tot_Drug_Cst)2017 Drug cost: $1,407,904 (USD; Tot_Drug_Cst)2018 Drug cost: $1,861,678 (USD; Tot_Drug_Cst)2019 Drug cost: $2,587,814 (USD; Tot_Drug_Cst)2020 Drug cost: $4,019,605 (USD; Tot_Drug_Cst)2021 Drug cost: $4,436,511 (USD; Tot_Drug_Cst)2022 Drug cost: $6,021,679 (USD; Tot_Drug_Cst)2023 Drug cost: $5,618,739 (USD; Tot_Drug_Cst)2024 Drug cost: $7,463,935 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155592,676$756,699
20165792,669$1,041,689
20176652,958$1,407,904
20187223,331$1,861,678
20197463,518$2,587,814
20207393,694$4,019,605
20217183,373$4,436,511
20226913,179$6,021,679
20237743,161$5,618,739
20249473,649$7,463,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$19K$39K2015 Medicare payment: $27,378 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $38,866 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $24,567 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $16,564 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $19,399 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $28,090 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $9,176 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $9,980 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $14,241 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $21,791 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201515169$27,378
201615252$38,866
201711231$24,567
201814106$16,564
20191480$19,399
2020N/R97$28,090
2021N/R54$9,176
2022N/R55$9,980
2023N/R44$14,241
2024N/R53$21,791

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more537827$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more242271$61
84153Psa (prostate specific antigen) measurement, total181216$18
36415Insertion of needle into vein for collection of blood sample184221$9
81001Manual urinalysis test with examination using microscope, automated538790$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErleadaApalutamide1906,000$2,989,035
XtandiEnzalutamide1785,340$2,451,210
NubeqaDarolutamide1354,080$1,826,811
MyrbetriqMirabegron624,254$66,133
OrgovyxRelugolix18540$49,069

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R13$12,251
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R40$9,539

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.224$152,152Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.42$374,224PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lawrence A. Gervasi, MD?

Tedicare shows public-source Medicare data for Lawrence A. Gervasi, MD (NPI 1265400592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lawrence A. Gervasi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lawrence A. Gervasi, MD?

Lawrence A. Gervasi, MD is linked to SOUTHWEST UROLOGY, LLC (billing NPI 1962428136) in the available physician profile data.

Does Lawrence A. Gervasi, MD have Open Payments data?

Lawrence A. Gervasi, MD has 266 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.